Anji Xiong Selected Research

Anji Xiong Research Topics

2	Infections 02/2024 - 01/2021
2	Lung Diseases (Lung Disease) 12/2023 - 08/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 02/2024
1	Autoimmune Diseases (Autoimmune Disease) 02/2024
1	Connective Tissue Diseases (Connective Tissue Disease) 02/2024
1	Cytomegalovirus Infections (Inclusion Disease) 02/2024
1	Graves Ophthalmopathy 01/2024
1	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 01/2024
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2023
1	Lymphopenia (Lymphocytopenia) 12/2023
1	Guillain-Barre Syndrome 09/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2023
1	Polymyositis 04/2023
1	Dermatomyositis (Dermatopolymyositis) 04/2023
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2022
1	Systemic Scleroderma (Systemic Sclerosis) 06/2022
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2022
1	Muscle Weakness 01/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Leukopenia 01/2021
1	Muscular Diseases (Myopathy) 01/2021
1	Uveitis 01/2021
1	Spondylarthropathies 01/2021
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021
1	Immunoglobulin G4-Related Disease 08/2020
1	Lung Neoplasms (Lung Cancer) 08/2020
1	Fibrosis (Cirrhosis) 01/2017
1	Hypoxia (Hypoxemia) 01/2017

6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 01/2021
3	GlucocorticoidsIBA 02/2024 - 12/2023
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2023 - 01/2021
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2021
1	Vitamin D FDA LinkGeneric 02/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2024
1	Antiviral Agents (Antivirals)IBA 02/2024
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2024
1	telitaciceptIBA 01/2024
1	Methotrexate (Mexate)FDA LinkGeneric 12/2023
1	Calcineurin InhibitorsIBA 12/2023
1	Azathioprine (Imuran)FDA LinkGeneric 12/2023
1	Intravenous Immunoglobulins (IVIG)FDA Link 04/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2022
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2021
1	Infliximab (Remicade)FDA Link 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Antinuclear AntibodiesIBA 01/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2021
1	Signal Recognition ParticleIBA 01/2021
1	Immunoglobulin G (IgG)IBA 08/2020